Regeneron Pharmaceuticals (Nasdaq: REGN) is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions.
Recent Mentions on Fool.com
- How Big of an Impact Could Praluent Have on Regeneron Pharmaceuticals Inc.?
- Regeneron Earnings Shine, but All Eyes Are on the Pipeline
- The 3 Best Stocks for Investing in Cholesterol Drugs
- 3 Potential Blockbuster Drugs That Could Be Approved Before Year's End
- Following Gilead Sciences, Inc., Which Biotech Will Pay a Dividend Next?